Novo’s Layoffs, Novartis’ $1.4B Buy, Pancreatic Cancer Progress — This Week in Biotech #69
12 Sep 2025
Contributed by Lukas
Subscribe to Biotech Blueprint, your free biotech & pharma newsletter released every Friday at b...
Ionis' Olezarsen Win, Novartis Licenses Arrowhead, CDC Vaccine Fight — This Week in Biotech #68
05 Sep 2025
Contributed by Lukas
Subscribe to Biotech Blueprint FREE weekly newsletter HERE.
Monarez Fired, Novo’s srRNA Deal, ImmunityBio Wows in GBM — This Week in Biotech #67
29 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE or at biotechblueprint.com
Viking Falls on Obesity Pill, Rocket’s Gene Therapy Resumes, FDA Greenlights Papzimeos — This Week in Biotech #66
22 Aug 2025
Contributed by Lukas
Subscribe to the Biotech Blueprint weekly newsletter for free HERE. Thanks for your support.
Lilly Bets on AI, Prasad Returns, and Brinsupri Breaks Through - This Week in Biotech #65
15 Aug 2025
Contributed by Lukas
Get the latest biotech and pharma news for free straight in your inbox. Follow Biotech Blueprint HER...
RFK Jr. Ends mRNA Funding, Sarepta Beats Q2, and Eli Lilly Falls — This Week in Biotech #64
08 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free for weekly newsletters right in your inbox. Thanks for your ...
FDA Shake Up, Sarepta Rebounds, and Trump Targets Drug Prices — This Week in #Biotech 63
01 Aug 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE and visit Biotech Blueprint website for more.
Sarepta, Elevidys, and the Future of AAV Gene Therapy
29 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE and to Biotech Capital Compass HERE.In this episode of the Biote...
Sarepta’s Gene Therapy Crisis Deepens — This Week in Biotech #62
25 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE.
Sarepta’s $400M Pivot, MiNK’s 500% Surge, and AML Breakthroughs — This Week in Biotech #61
18 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint for free HERE.In this episode: Layoffs, CRLs, and standout trial data...
CRISPR in 2025: Clinical Use, Regulatory Pressure, and Future Promise
18 Jul 2025
Contributed by Lukas
Welcome back to Biotech Blueprint!In this week’s special episode, I teamed up with the Biotech Cap...
KalVista’s FDA Win, Merck’s $10B Deal, and CRISPR Momentum — Biotech #60
14 Jul 2025
Contributed by Lukas
Subscribe to our free newsletter HERE.Thanks for listening!
Sparks Fly in Biotech — This Week in Biotech #59
03 Jul 2025
Contributed by Lukas
Subscribe to Biotech Blueprint HERE.While the U.S. gears up for Independence Day, biotech is having ...
FDA Drama & Psychedelic Setback — This Week in Biotech #58
27 Jun 2025
Contributed by Lukas
Subscribe for FREE HERE.FDA turmoil impacts key drug decisions, Compass’s phase 3 psilocybin data ...
HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57
20 Jun 2025
Contributed by Lukas
Subscribe for free HERE. Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA ref...
Biotech Caught Between AI Momentum and Political Turbulence — This Week in Biotech #56
13 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint, FREE weekly newsletter HERE. This week, Biotech Blueprint breaks dow...
Navigating Biotech Jobs in 2025: AI, Networking, and Career Strategy
11 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint 👉HERE.In this episode of the Biotech Blueprint Podcast, host Kater...
ASCO Breakthroughs, Gene Therapy Stumbles, and Omada's IPO debut — This Week in Biotech #55
09 Jun 2025
Contributed by Lukas
Subscribe to Biotech Blueprint here.In this week’s episode, I break down the biggest stories shapi...
CRISPR Setbacks, Vaccine Policy Reversed, and an Oral Antibiotic Breakthrough — This Week in Biotech #54
02 Jun 2025
Contributed by Lukas
In this week’s recap, we spotlight three biotech stories that reveal where the sector is headed, b...
Organoids, AI, and the FDA’s Move Away from Animal Models
29 May 2025
Contributed by Lukas
Is this the end of animal testing? | Biotech Blueprint PodcastFor nearly a century, animal testing h...
Tighter Boosters, Novavax's Win, and Psychedelic Signals — This Week in Biotech #53
23 May 2025
Contributed by Lukas
In this week’s recap, we cover three biotech stories that signal big shifts in regulation:FDA tigh...
Medicare Benchmarking, Novo's Transition, and Biohaven's Setback — This Week in Biotech #52
19 May 2025
Contributed by Lukas
In this week’s episode, we break down three major biotech stories from May 9–16, 2025:• The Wh...
CRISPR, Prasad, and the NIH budget bomb — This Week in Biotech #51
11 May 2025
Contributed by Lukas
This Week in Biotech #51 (May 2–10, 2025)CRISPR’s cholesterol breakthrough, the FDA’s new CBER...
From Wall Street to Wet Lab: Mapping the Future of Biotech
03 May 2025
Contributed by Lukas
Biotech Blueprint is a newsletter and a podcast where biotech professionals and industry insiders co...